Table of Contents
113 relations: Active metabolite, Adrenal insufficiency, Adverse drug reaction, Agonist, Agonist-antagonist, Alcohol (drug), Allergy, Alternative splicing, Benzodiazepine, Bile, Bile duct, Bioavailability, Biological activity, Biological half-life, Breastfeeding, Buccal administration, Buprenorphine-3-glucuronide, Buprenorphine/naloxone, Buprenorphine/samidorphan, Central sleep apnea, Chronic pain, Clinical trial, Cocaine dependence, Combination drug, Constipation, Controlled substance, Controlled Substances Act, CYP2C8, CYP3A4, Cytochrome P450, Diário Oficial da União, Drug Addiction Treatment Act, Drug-induced QT prolongation, Elimination (pharmacology), Enzyme, Equianalgesic, Euphoria, Excretion, Exon, First pass effect, Food and Drug Administration, Glucuronidation, Glucuronide, Health Canada, Heroin, Hydrochloride, Hypotension, Hypoventilation, IC50, Implant (medicine), ... Expand index (63 more) »
- Cat medications
- Delta-opioid receptor antagonists
- Dog medications
- Drugs developed by Schering-Plough
- Kappa-opioid receptor antagonists
- Nociceptin receptor agonists
- Nociceptin receptor antagonists
- Oripavines
Active metabolite
An active metabolite, or pharmacologically active metabolite is a biologically active metabolite of a xenobiotic substance, such as a drug or environmental chemical.
See Buprenorphine and Active metabolite
Adrenal insufficiency
Adrenal insufficiency is a condition in which the adrenal glands do not produce adequate amounts of steroid hormones.
See Buprenorphine and Adrenal insufficiency
Adverse drug reaction
An adverse drug reaction (ADR) is a harmful, unintended result caused by taking medication.
See Buprenorphine and Adverse drug reaction
Agonist
An agonist is a chemical that activates a receptor to produce a biological response.
Agonist-antagonist
In pharmacology the term agonist-antagonist or mixed agonist/antagonist is used to refer to a drug which under some conditions behaves as an agonist (a substance that fully activates the receptor that it binds to) while under other conditions, behaves as an antagonist (a substance that binds to a receptor but does not activate and can block the activity of other agonists).
See Buprenorphine and Agonist-antagonist
Alcohol (drug)
Alcohol, sometimes referred to by the chemical name ethanol, is one of the most widely used and abused psychoactive drugs in the world and falls under the depressant category. Buprenorphine and Alcohol (drug) are Euphoriants.
See Buprenorphine and Alcohol (drug)
Allergy
Allergies, also known as allergic diseases, are various conditions caused by hypersensitivity of the immune system to typically harmless substances in the environment.
Alternative splicing
Alternative splicing, or alternative RNA splicing, or differential splicing, is an alternative splicing process during gene expression that allows a single gene to produce different splice variants.
See Buprenorphine and Alternative splicing
Benzodiazepine
Benzodiazepines (BZD, BDZ, BZs), colloquially called "benzos", are a class of depressant drugs whose core chemical structure is the fusion of a benzene ring and a diazepine ring.
See Buprenorphine and Benzodiazepine
Bile
Bile (from Latin bilis), or gall, is a yellow-green fluid produced by the liver of most vertebrates that aids the digestion of lipids in the small intestine.
Bile duct
A bile duct is any of a number of long tube-like structures that carry bile, and is present in most vertebrates.
See Buprenorphine and Bile duct
Bioavailability
In pharmacology, bioavailability is a subcategory of absorption and is the fraction (%) of an administered drug that reaches the systemic circulation.
See Buprenorphine and Bioavailability
Biological activity
In pharmacology, biological activity or pharmacological activity describes the beneficial or adverse effects of a drug on living matter.
See Buprenorphine and Biological activity
Biological half-life
Biological half-life (elimination half-life, pharmacological half-life) is the time taken for concentration of a biological substance (such as a medication) to decrease from its maximum concentration (Cmax) to half of Cmax in the blood plasma.
See Buprenorphine and Biological half-life
Breastfeeding
Breastfeeding, variously known as chestfeeding or nursing, is the process where breast milk is fed to a child.
See Buprenorphine and Breastfeeding
Buccal administration
Buccal administration is a topical route of administration by which drugs held or applied in the buccal area (in the cheek) diffuse through the oral mucosa (tissues which line the mouth) and enter directly into the bloodstream.
See Buprenorphine and Buccal administration
Buprenorphine-3-glucuronide
Buprenorphine-3-glucuronide (B3G) is a major active metabolite of the opioid modulator buprenorphine. Buprenorphine and buprenorphine-3-glucuronide are Oripavines and Tertiary alcohols.
See Buprenorphine and Buprenorphine-3-glucuronide
Buprenorphine/naloxone
Buprenorphine/naloxone, sold under the brand name Suboxone among others, is a fixed-dose combination medication that includes buprenorphine and naloxone. Buprenorphine and Buprenorphine/naloxone are drug rehabilitation, drugs developed by Merck & Co., drugs developed by Schering-Plough, kappa-opioid receptor antagonists, mu-opioid receptor agonists, Oripavines and Semisynthetic opioids.
See Buprenorphine and Buprenorphine/naloxone
Buprenorphine/samidorphan
Buprenorphine/samidorphan (developmental code name ALKS-5461) is a combination formulation of buprenorphine and samidorphan which is under development as an add on to antidepressants in treatment-resistant depression (TRD). Buprenorphine and Buprenorphine/samidorphan are Delta-opioid receptor antagonists, drug rehabilitation, kappa-opioid receptor antagonists, nociceptin receptor agonists, nociceptin receptor antagonists and Semisynthetic opioids.
See Buprenorphine and Buprenorphine/samidorphan
Central sleep apnea
Central sleep apnea (CSA) or central sleep apnea syndrome (CSAS) is a sleep-related disorder in which the effort to breathe is diminished or absent, typically for 10 to 30 seconds either intermittently or in cycles, and is usually associated with a reduction in blood oxygen saturation.
See Buprenorphine and Central sleep apnea
Chronic pain
Chronic pain or chronic pain syndrome is a type of pain that is also known by other titles such as gradual burning pain, electrical pain, throbbing pain, and nauseating pain.
See Buprenorphine and Chronic pain
Clinical trial
Clinical trials are prospective biomedical or behavioral research studies on human participants designed to answer specific questions about biomedical or behavioral interventions, including new treatments (such as novel vaccines, drugs, dietary choices, dietary supplements, and medical devices) and known interventions that warrant further study and comparison.
See Buprenorphine and Clinical trial
Cocaine dependence
Cocaine dependence is a neurological disorder that is characterized by withdrawal symptoms upon cessation from cocaine use.
See Buprenorphine and Cocaine dependence
Combination drug
A combination drug or a fixed-dose combination (FDC) is a medicine that includes two or more active ingredients combined in a single dosage form.
See Buprenorphine and Combination drug
Constipation
Constipation is a bowel dysfunction that makes bowel movements infrequent or hard to pass.
See Buprenorphine and Constipation
Controlled substance
A controlled substance is generally a drug or chemical whose manufacture, possession and use is regulated by a government, such as illicitly used drugs or prescription medications that are designated by law.
See Buprenorphine and Controlled substance
Controlled Substances Act
The Controlled Substances Act (CSA) is the statute establishing federal U.S. drug policy under which the manufacture, importation, possession, use, and distribution of certain substances is regulated.
See Buprenorphine and Controlled Substances Act
CYP2C8
Cytochrome P4502C8 (CYP2C8) is a member of the cytochrome P450 mixed-function oxidase system involved in the metabolism of xenobiotics in the body.
CYP3A4
Cytochrome P450 3A4 (abbreviated CYP3A4) is an important enzyme in the body, mainly found in the liver and in the intestine, which in humans is encoded by CYP3A4 gene.
Cytochrome P450
Cytochromes P450 (P450s or CYPs) are a superfamily of enzymes containing heme as a cofactor that mostly, but not exclusively, function as monooxygenases.
See Buprenorphine and Cytochrome P450
Diário Oficial da União
The Diário Oficial da União (literally Official Diary of the Union), abbreviated DOU, is the official journal of the federal government of Brazil.
See Buprenorphine and Diário Oficial da União
Drug Addiction Treatment Act
The Drug Addiction Treatment Act of 2000 (DATA 2000), Title XXXV, Section 3502 of the Children's Health Act, permits physicians who meet certain qualifications to treat opioid addiction with Schedule III, IV, and V narcotic medications that have been specifically approved by the Food and Drug Administration for that indication.
See Buprenorphine and Drug Addiction Treatment Act
Drug-induced QT prolongation
QT prolongation is a measure of delayed ventricular repolarisation, which means the heart muscle takes longer than normal to recharge between beats.
See Buprenorphine and Drug-induced QT prolongation
Elimination (pharmacology)
In pharmacology, the elimination or excretion of a drug is understood to be any one of a number of processes by which a drug is eliminated (that is, cleared and excreted) from an organism either in an unaltered form (unbound molecules) or modified as a metabolite.
See Buprenorphine and Elimination (pharmacology)
Enzyme
Enzymes are proteins that act as biological catalysts by accelerating chemical reactions.
Equianalgesic
An equianalgesic chart is a conversion chart that lists equivalent doses of analgesics (drugs used to relieve pain).
See Buprenorphine and Equianalgesic
Euphoria
Euphoria is the experience (or affect) of pleasure or excitement and intense feelings of well-being and happiness. Buprenorphine and Euphoria are Euphoriants.
See Buprenorphine and Euphoria
Excretion
Excretion is elimination of metabolic waste, which is an essential process in all organisms.
See Buprenorphine and Excretion
Exon
An exon is any part of a gene that will form a part of the final mature RNA produced by that gene after introns have been removed by RNA splicing.
First pass effect
The first pass effect (also known as first-pass metabolism or presystemic metabolism) is a phenomenon of drug metabolism at a specific location in the body which leads to a reduction in the concentration of the active drug before it reaches the site of action or systemic circulation.
See Buprenorphine and First pass effect
Food and Drug Administration
The United States Food and Drug Administration (FDA or US FDA) is a federal agency of the Department of Health and Human Services.
See Buprenorphine and Food and Drug Administration
Glucuronidation
Glucuronidation is often involved in drug metabolism of substances such as drugs, pollutants, bilirubin, androgens, estrogens, mineralocorticoids, glucocorticoids, fatty acid derivatives, retinoids, and bile acids.
See Buprenorphine and Glucuronidation
Glucuronide
A glucuronide, also known as glucuronoside, is any substance produced by linking glucuronic acid to another substance via a glycosidic bond.
See Buprenorphine and Glucuronide
Health Canada
Health Canada (HC; Santé Canada, SC)Health Canada is the applied title under the Federal Identity Program; the legal title is Department of Health.
See Buprenorphine and Health Canada
Heroin
Heroin, also known as diacetylmorphine and diamorphine among other names, is a morphinan opioid substance synthesized from the dried latex of the Papaver somniferum plant; it is mainly used as a recreational drug for its euphoric effects. Buprenorphine and Heroin are Euphoriants, mu-opioid receptor agonists and Semisynthetic opioids.
Hydrochloride
In chemistry, a hydrochloride is an acid salt resulting, or regarded as resulting, from the reaction of hydrochloric acid with an organic base (e.g. an amine).
See Buprenorphine and Hydrochloride
Hypotension
Hypotension, also known as low blood pressure, is a cardiovascular condition characterized by abnormally reduced blood pressure.
See Buprenorphine and Hypotension
Hypoventilation
Hypoventilation (also known as respiratory depression) occurs when ventilation is inadequate (hypo meaning "below") to perform needed respiratory gas exchange.
See Buprenorphine and Hypoventilation
IC50
Half maximal inhibitory concentration (IC50) is a measure of the potency of a substance in inhibiting a specific biological or biochemical function.
Implant (medicine)
An implant is a medical device manufactured to replace a missing biological structure, support a damaged biological structure, or enhance an existing biological structure.
See Buprenorphine and Implant (medicine)
Injection (medicine)
An injection (often and usually referred to as a "shot" in US English, a "jab" in UK English, or a "jag" in Scottish English and Scots) is the act of administering a liquid, especially a drug, into a person's body using a needle (usually a hypodermic needle) and a syringe.
See Buprenorphine and Injection (medicine)
Intramuscular injection
Intramuscular injection, often abbreviated IM, is the injection of a substance into a muscle.
See Buprenorphine and Intramuscular injection
Intravenous therapy
Intravenous therapy (abbreviated as IV therapy) is a medical technique that administers fluids, medications and nutrients directly into a person's vein.
See Buprenorphine and Intravenous therapy
Isozyme
In biochemistry, isozymes (also known as isoenzymes or more generally as multiple forms of enzymes) are enzymes that differ in amino acid sequence but catalyze the same chemical reaction.
Μ-opioid receptor
The μ-opioid receptors (MOR) are a class of opioid receptors with a high affinity for enkephalins and beta-endorphin, but a low affinity for dynorphins.
See Buprenorphine and Μ-opioid receptor
Kidney
In humans, the kidneys are two reddish-brown bean-shaped blood-filtering organs that are a multilobar, multipapillary form of mammalian kidneys, usually without signs of external lobulation.
Kidney failure
Kidney failure, also known as end-stage renal disease (ESRD), is a medical condition in which the kidneys can no longer adequately filter waste products from the blood, functioning at less than 15% of normal levels. Kidney failure is classified as either acute kidney failure, which develops rapidly and may resolve; and chronic kidney failure, which develops slowly and can often be irreversible.
See Buprenorphine and Kidney failure
Liver
The liver is a major metabolic organ exclusively found in vertebrate animals, which performs many essential biological functions such as detoxification of the organism, and the synthesis of proteins and various other biochemicals necessary for digestion and growth.
Local anesthetic
A local anesthetic (LA) is a medication that causes absence of all sensation (including pain) in a specific body part without loss of consciousness, providing local anesthesia, as opposed to a general anesthetic, which eliminates all sensation in the entire body and causes unconsciousness.
See Buprenorphine and Local anesthetic
Medical imaging
Medical imaging is the technique and process of imaging the interior of a body for clinical analysis and medical intervention, as well as visual representation of the function of some organs or tissues (physiology).
See Buprenorphine and Medical imaging
Metabolism
Metabolism (from μεταβολή metabolē, "change") is the set of life-sustaining chemical reactions in organisms.
See Buprenorphine and Metabolism
Methadone
Methadone, sold under the brand names Dolophine and Methadose among others, is a synthetic opioid agonist used for chronic pain and also for opioid use disorder. Buprenorphine and Methadone are CYP2D6 inhibitors, drug rehabilitation, Euphoriants and mu-opioid receptor agonists.
See Buprenorphine and Methadone
Microdosing
Microdosing, or micro-dosing, involves the administration of sub-therapeutic doses of drugs to study their effects in humans, aiming to gather preliminary data on safety, pharmacokinetics, and potential therapeutic benefits without producing significant physiological effects.
See Buprenorphine and Microdosing
Miosis
Miosis, or myosis, is excessive constriction of the pupil.
Naloxone
Naloxone is an opioid antagonist: a medication used to reverse or reduce the effects of opioids. Buprenorphine and Naloxone are kappa-opioid receptor antagonists and Tertiary alcohols.
See Buprenorphine and Naloxone
Nasal administration
Nasal administration, popularly known as snorting, is a route of administration in which drugs are insufflated through the nose.
See Buprenorphine and Nasal administration
Neonatal withdrawal
Neonatal withdrawal or neonatal abstinence syndrome (NAS) or neonatal opioid withdrawal syndrome (NOWS) is a withdrawal syndrome of infants, caused by the cessation of the administration of licit or illicit drugs.
See Buprenorphine and Neonatal withdrawal
Netherlands
The Netherlands, informally Holland, is a country located in Northwestern Europe with overseas territories in the Caribbean.
See Buprenorphine and Netherlands
Nociceptin receptor
The nociceptin opioid peptide receptor (NOP), also known as the nociceptin/orphanin FQ (N/OFQ) receptor or kappa-type 3 opioid receptor, is a protein that in humans is encoded by the OPRL1 (opioid receptor-like 1) gene.
See Buprenorphine and Nociceptin receptor
Norbuprenorphine
Norbuprenorphine is a major active metabolite of the opioid modulator buprenorphine. Buprenorphine and Norbuprenorphine are ethers, mu-opioid receptor agonists, nociceptin receptor agonists, Phenols and Tertiary alcohols.
See Buprenorphine and Norbuprenorphine
Norbuprenorphine-3-glucuronide
Norbuprenorphine-3-glucuronide (N3G) is a major active metabolite of the opioid modulator buprenorphine. Buprenorphine and Norbuprenorphine-3-glucuronide are ethers, Phenols and Tertiary alcohols.
See Buprenorphine and Norbuprenorphine-3-glucuronide
Opioid
Opioids are a class of drugs that derive from, or mimic, natural substances found in the opium poppy plant.
Opioid agonist therapy
Opioid agonist therapy (OAT) is a treatment in which prescribed opioid agonists are given to patients who live with Opioid use disorder (OUD). Buprenorphine and opioid agonist therapy are mu-opioid receptor agonists.
See Buprenorphine and Opioid agonist therapy
Opioid modulator
An opioid modulator (or opioid receptor modulator) is a drug which has mixed agonist and antagonist actions at different opioid receptors and thus cannot clearly be described as either an opioid agonist or antagonist.
See Buprenorphine and Opioid modulator
Opioid receptor
Opioid receptors are a group of inhibitory G protein-coupled receptors with opioids as ligands.
See Buprenorphine and Opioid receptor
Opioid use disorder
Opioid use disorder (OUD) is a substance use disorder characterized by cravings for opioids, continued use despite physical and/or psychological deterioration, increased tolerance with use, and withdrawal symptoms after discontinuing opioids.
See Buprenorphine and Opioid use disorder
Opioid withdrawal
Opioid withdrawal is a set of symptoms (a syndrome) arising from the sudden withdrawal or reduction of opioids where previous usage has been heavy and prolonged. Buprenorphine and opioid withdrawal are drug rehabilitation.
See Buprenorphine and Opioid withdrawal
Opium Law
The Opium Law (Opiumwet in Dutch) is the section of the Dutch law which covers nearly all psychotropic drugs.
See Buprenorphine and Opium Law
Oral administration
| name.
See Buprenorphine and Oral administration
Orthostatic hypotension
Orthostatic hypotension, also known as postural hypotension, is a medical condition wherein a person's blood pressure drops when standing up or sitting down.
See Buprenorphine and Orthostatic hypotension
P-glycoprotein
P-glycoprotein 1 (permeability glycoprotein, abbreviated as P-gp or Pgp) also known as multidrug resistance protein 1 (MDR1) or ATP-binding cassette sub-family B member 1 (ABCB1) or cluster of differentiation 243 (CD243) is an important protein of the cell membrane that pumps many foreign substances out of cells.
See Buprenorphine and P-glycoprotein
Pain
Pain is a distressing feeling often caused by intense or damaging stimuli.
Pain management
Pain management is an aspect of medicine and health care involving relief of pain (pain relief, analgesia, pain control) in various dimensions, from acute and simple to chronic and challenging.
See Buprenorphine and Pain management
Partial agonist
In pharmacology, partial agonists are drugs that bind to and activate a given receptor, but have only partial efficacy at the receptor relative to a full agonist.
See Buprenorphine and Partial agonist
Perioperative
The perioperative period is the period of a patient's surgical procedure.
See Buprenorphine and Perioperative
Physical dependence
Physical dependence is a physical condition caused by chronic use of a tolerance-forming drug, in which abrupt or gradual drug withdrawal causes unpleasant physical symptoms.
See Buprenorphine and Physical dependence
Positron emission tomography
Positron emission tomography (PET) is a functional imaging technique that uses radioactive substances known as radiotracers to visualize and measure changes in metabolic processes, and in other physiological activities including blood flow, regional chemical composition, and absorption.
See Buprenorphine and Positron emission tomography
Pregnancy
Pregnancy is the time during which one or more offspring develops (gestates) inside a woman's uterus (womb).
See Buprenorphine and Pregnancy
Psychological dependence
Psychological dependence is a cognitive disorder that involves emotional–motivational withdrawal symptoms – such as anxiety or anhedonia – upon cessation of prolonged drug abuse or certain repetitive behaviors.
See Buprenorphine and Psychological dependence
Receptor antagonist
A receptor antagonist is a type of receptor ligand or drug that blocks or dampens a biological response by binding to and blocking a receptor rather than activating it like an agonist.
See Buprenorphine and Receptor antagonist
Reckitt
Reckitt Benckiser is a British-Dutch multinational consumer goods company headquartered in Slough, United Kingdom, and Hoofddorp, Netherlands.
Rectal administration
Rectal administration (colloquially known as boofing or plugging) uses the rectum as a route of administration for medication and other fluids, which are absorbed by the rectum's blood vessels,The rectum has numerous blood vessels available to absorb drugs: upwards 2/3rds of the dose bypasses first-pass metabolism through systemic distribution and the rest is taken through the liver and metabolized via the hepatic portal system.
See Buprenorphine and Rectal administration
Samidorphan
Samidorphan (developmental code names ALKS-33, RDC-0313) is an opioid antagonist that in the form of olanzapine/samidorphan (brand name Lybalvi) is used in the treatment of schizophrenia and bipolar disorder.
See Buprenorphine and Samidorphan
Seizure
A seizure is a period of symptoms due to abnormally excessive or synchronous neuronal activity in the brain.
Sigma receptor
Sigma receptors (σ-receptors) are protein receptors that bind ligands such as 4-PPBP (4-phenyl-1-(4-phenylbutyl) piperidine), SA 4503 (cutamesine), ditolylguanidine, dimethyltryptamine, and siramesine.
See Buprenorphine and Sigma receptor
Sigma-1 receptor
The sigma-1 receptor (σ1R), one of two sigma receptor subtypes, is a chaperone protein at the endoplasmic reticulum (ER) that modulates calcium signaling through the IP3 receptor.
See Buprenorphine and Sigma-1 receptor
Sigma-2 receptor
The sigma-2 receptor (σ2R) is a sigma receptor subtype that has attracted attention due to its involvement in diseases such as neurological diseases, neurodegenerative, neuro-ophthalmic and cancer.
See Buprenorphine and Sigma-2 receptor
Subcutaneous administration
Subcutaneous administration is the insertion of medications beneath the skin either by injection or infusion.
See Buprenorphine and Subcutaneous administration
Sublingual administration
Sublingual (abbreviated SL), from the Latin for "under the tongue", refers to the pharmacological route of administration by which substances diffuse into the blood through tissues under the tongue.
See Buprenorphine and Sublingual administration
The New Republic
The New Republic is an American publisher focused on domestic politics, news, culture, and the arts, with ten magazines a year and a daily online platform.
See Buprenorphine and The New Republic
Thebaine
Thebaine (paramorphine), also known as codeine methyl enol ether, is an opiate alkaloid, its name coming from the Greek Θῆβαι, Thēbai (Thebes), an ancient city in Upper Egypt. Buprenorphine and Thebaine are ethers.
See Buprenorphine and Thebaine
Therapeutic Goods Administration
The Therapeutic Goods Administration (TGA) is the medicine and therapeutic regulatory agency of the Australian Government.
See Buprenorphine and Therapeutic Goods Administration
Toll-like receptor 4
Toll-like receptor 4 (TLR4), also designated as CD284 (cluster of differentiation 284), is a key activator of the innate immune response and plays a central role in the fight against bacterial infections.
See Buprenorphine and Toll-like receptor 4
Transdermal
Transdermal is a route of administration wherein active ingredients are delivered across the skin for systemic distribution.
See Buprenorphine and Transdermal
Transdermal patch
A transdermal patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream.
See Buprenorphine and Transdermal patch
Treatment-resistant depression
Treatment-resistant depression (TRD) is a form of major depressive disorder (MDD) in which an affected person does not respond adequately to a course of appropriate antidepressant medication.
See Buprenorphine and Treatment-resistant depression
UDP glucuronosyltransferase 1 family, polypeptide A1
UDP-glucuronosyltransferase 1-1 also known as UGT-1A is an enzyme that in humans is encoded by the UGT1A1 gene.
See Buprenorphine and UDP glucuronosyltransferase 1 family, polypeptide A1
UGT1A3
UDP-glucuronosyltransferase 1-3 is an enzyme that in humans is encoded by the UGT1A3 gene.
UGT2B7
UGT2B7 (UDP-Glucuronosyltransferase-2B7) is a phase II metabolism isoenzyme found to be active in the liver, kidneys, epithelial cells of the lower gastrointestinal tract and also has been reported in the brain.
Urinary retention
Urinary retention is an inability to completely empty the bladder.
See Buprenorphine and Urinary retention
Voltage-gated sodium channel
Voltage-gated sodium channels (VGSCs), also known as voltage-dependent sodium channels (VDSCs), are a group of voltage-gated ion channels found in the membrane of excitable cells (e.g., muscle, glial cells, neurons, etc.) with a permeability to the sodium ion Na+.
See Buprenorphine and Voltage-gated sodium channel
WHO Model List of Essential Medicines
The WHO Model List of Essential Medicines (aka Essential Medicines List or EML), published by the World Health Organization (WHO), contains the medications considered to be most effective and safe to meet the most important needs in a health system.
See Buprenorphine and WHO Model List of Essential Medicines
Wired (magazine)
Wired (stylized in all caps) is a monthly American magazine, published in print and online editions, that focuses on how emerging technologies affect culture, the economy, and politics.
See Buprenorphine and Wired (magazine)
See also
Cat medications
- Amlodipine
- Amoxicillin/clavulanic acid
- Artificial tears
- Bexagliflozin
- Buprenorphine
- Butorphanol
- Capromorelin
- Cefalexin
- Cefovecin
- Dinotefuran
- Esafoxolaner/eprinomectin/praziquantel
- Fluralaner
- Frunevetmab
- Lotilaner
- Maropitant
- Meloxicam
- Milbemycin oxime
- Molidustat
- Nitenpyram
- Sarolaner
- Selamectin
- Spinosad
- Tepoxalin
- Velagliflozin
Delta-opioid receptor antagonists
- AT-076
- Apigenin
- Buprenorphine
- Buprenorphine/samidorphan
- Diacetylnalorphine
- Diprenorphine
- Eluxadoline
- JDTic
- Nalmefene
- Naltrexone
- Naltriben
- Naltrindole
- Naringenin
- Noribogaine
- Pawhuskin A
- Quadazocine
- SoRI-9409
- Thienorphine
Dog medications
- Afoxolaner
- Amlodipine
- Amoxicillin/clavulanic acid
- Artificial tears
- Atipamezole
- Bedinvetmab
- Buprenorphine
- Butorphanol
- Capromorelin
- Carprofen
- Cefalexin
- Cefovecin
- DA2PPC vaccine
- Deracoxib
- Dinotefuran
- Dirlotapide
- Firocoxib
- Fluralaner
- Grapiprant
- Imidacloprid/permethrin/pyriproxyfen
- Lokivetmab
- Lotilaner
- Lufenuron
- Maropitant
- Medetomidine/vatinoxan
- Meloxicam
- Milbemycin oxime
- Nitenpyram
- Oclacitinib
- Orbifloxacin
- Osaterone acetate
- Phytomenadione
- Pimobendan
- Rabacfosadine
- Sarolaner
- Selamectin
- Spinosad
- Tepoxalin
- Terbinafine/betamethasone acetate
- Toceranib
- Torasemide
- Trilostane
- Zeuterin
Drugs developed by Schering-Plough
- Asenapine
- BCG vaccine
- Bain de Soleil
- Buprenorphine
- Buprenorphine/naloxone
- Coppertone (sunscreen)
- Coricidin
- Desloratadine
- Desogestrel
- Dr. Scholl's
- Eptifibatide
- Esmirtazapine
- Ethinylestradiol/etonogestrel
- Ezetimibe
- Ezetimibe/simvastatin
- Famciclovir
- Formoterol
- Golimumab
- Gonadotropin preparations
- Human chorionic gonadotropin
- Infliximab
- Interferon alfa-2b
- Loratadine
- Lynestrenol
- Mianserin
- Mirtazapine
- Mometasone
- Nandrolone
- Oxymetazoline
- Pancuronium bromide
- Peginterferon alfa-2b
- Posaconazole
- Risperidone
- Rocuronium bromide
- Temozolomide
- Testosterone propionate/testosterone phenylpropionate/testosterone isocaproate/testosterone decanoate
- Tibolone
- Triamcinolone
- Urofollitropin
- Vardenafil
- Vecuronium bromide
- Zinka
Kappa-opioid receptor antagonists
- 4',7-Dihydroxyflavone
- 5'-Guanidinonaltrindole
- 6'-Guanidinonaltrindole
- 6β-Naltrexol
- 6β-Naltrexol-d4
- AT-076
- Amentoflavone
- Apigenin
- Aticaprant
- Axelopran
- BU09059
- Binaltorphimine
- Buprenorphine
- Buprenorphine/naloxone
- Buprenorphine/naltrexone
- Buprenorphine/samidorphan
- CVL-354
- Dezocine
- Diprenorphine
- Epicatechin gallate
- Hyperoside
- JDTic
- KSC-12-192
- LY-2459989
- LY-255582
- Methylnaltrexone
- Morphine/naltrexone
- Nalorphine dinicotinate
- Naloxone
- Naltrexone
- Naltrexone/bupropion
- Naringenin
- Navacaprant
- Norbinaltorphimine
- Noribogaine
- PF-4455242
- Pawhuskin A
- Quadazocine
- RB-64
- Taxifolin
- Zyklophin
Nociceptin receptor agonists
- AT-121
- Buprenorphine
- Buprenorphine/samidorphan
- Cebranopadol
- Etorphine
- Levomethorphan
- Levorphanol
- MCOPPB
- NNC 63-0532
- Nociceptin
- Norbuprenorphine
- Ro64-6198
- Ro65-6570
- Sunobinop
Nociceptin receptor antagonists
- AT-076
- BTRX-246040
- Buprenorphine
- Buprenorphine/samidorphan
- J-113,397
- JTC-801
- SB-612,111
- Thienorphine
Oripavines
- 18,19-Dehydrobuprenorphine
- Buprenorphine
- Buprenorphine-3-glucuronide
- Buprenorphine/naloxone
- Buprenorphine/naltrexone
- Oripavine
- TH-030418
- Thienorphine
References
Also known as ATC code N02AE01, ATC code N07BC01, ATCvet code QN02AE01, ATCvet code QN07BC01, Belbuca, Brixadi, Bupe, Bupernorphine, Bupomorphine, Bupredermal, Buprel, Buprenex, Buprenorphine Hydrochloride, Buprinex, Bupronorphine, Butrans, Buvidal, C29H41N1O4, C29H41NO4, Norspan, Probuphine, Sixmo, Sublocade, Subutex, Temgesic, Transtec, Vetergesic, Vetergesic multidose, Zorbium.